Asymchem Laboratories (Tianjin) Co., Ltd. (HKG:6821)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
83.15
+1.80 (2.21%)
At close: Mar 6, 2026
54.12%
Market Cap 39.70B
Revenue (ttm) 6.88B
Net Income (ttm) 1.14B
Shares Out n/a
EPS (ttm) 3.13
PE Ratio 34.96
Forward PE 25.69
Dividend 1.20 (1.57%)
Ex-Dividend Date Jun 25, 2025
Volume 301,400
Average Volume 216,627
Open 82.75
Previous Close 81.35
Day's Range 79.35 - 83.50
52-Week Range 39.95 - 116.60
Beta 0.23
RSI 54.16
Earnings Date Mar 31, 2026

About HKG:6821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical manufacturing, separations, crystallization, fermentation, continuous FlowGMP, non-GMP, Asymchem lab facilities and capabilities, commercial manufacturing... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9,595
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6821
Full Company Profile

Financial Performance

In 2024, HKG:6821's revenue was 5.80 billion, a decrease of -25.82% compared to the previous year's 7.83 billion. Earnings were 948.95 million, a decrease of -58.17%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.